Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TUCIDINOSTAT vs UBROGEPANT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TUCIDINOSTAT vs UBROGEPANT: Safety Overview

Metric TUCIDINOSTAT UBROGEPANT
Total FAERS Reports 251 2,531
Deaths Reported 63 49
Death Rate 25.1% 1.9%
Hospitalizations 58 145
Average Patient Age 53.7 yrs 49.2 yrs
% Female Patients 47.8% 83.6%
FDA Approval Date N/A Dec 23, 2019
Manufacturer N/A Allergan, Inc.
Route N/A ORAL
Marketing Status N/A Prescription